A smarter way to relieve severe pain

BioWave®’s patented, high-frequency neurostimulation is delivered through skin directly to pain nerves, inhibiting action potential propagation along the nerve and blocking transmission of pain signals to the brain. BioWave®’s active electrical field reduces pain and increases range of motion and function—8 hours on average and for many patients up to 24 hours following a 30-minute treatment(1). BioWave® is a 100% drug-free, wearable, FDA cleared and CE certified, smarter pain blocking technology

Wearable, comfortable and easy-to-use

Our non-invasive devices require no programming and have electrodes that can be easily placed over location of pain. Patients control intensity and comfort levels with a plus/minus button. Because treatments create a pleasantly deep, smooth sensation, patient compliance is excellent.

BioWave goes deeper

BioWave’s patented high frequency neurostimulation is delivered through skin directly to pain nerves, inhibiting action potential propagation along the nerve, blocking the transmission of pain signals to the brain.

BioWave
Innovative deep relief

TENS
Antiquated shallow reach

Recent Webinar

94%

of patients reported an improvement in quality of life after using BioWave for two weeks (1)

8 hours

of pain relief on average following a 30-minute treatment

3 points

average reduction in pain score (0-10 scale) after using BioWave for two weeks(1)

54%

of patients reduced or eliminated their pain medication consumption after using BioWave for two weeks(1)

(1) Open Label Pilot Study Investigating Non invasive High-Frequency Peripheral Nerve Fiber Stimulation In Chronic Pain Patients, outcomes from 463 study participants, published in the peer reviewed journal Pain Practice from the World Institute Of Pain.

Biowave-Howto-Knees_0005_Layer-14

Featured in clinical trials for osteoarthritis pain treatment

Brian J. Cole, MD, MBA; Richard Kang, MD, MS; Paul 8. Lewis, MD, MS; Adam Kramer, ATC; Jennifer K. Hayden, RN, MSN; Randomized Single-blinded Controlled Clinical Trial of a BiowavePENS device (Percutaneous Electrical Nerve Stimulation) versus Sham PENS treatment for the Osteoarthritic Knee. Orthopedics, June 2007, Volume 30, Number 6.

Results that change and improve daily life

BioWave brings better patient outcomes and higher levels of satisfaction than competing pain treatments. Patients find they feel better and do more.

The following data was compiled from patient surveys collected two or more weeks after the patient received their BioWave device.

image 59

Featured On